StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)

Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%

West Pharmaceutical Services cash

Cash and short-term investments held at the end of each period.

West Pharmaceutical Services's cash was $464.10M at Sep 30, 2026. For fiscal 2025 it was $791.30M, up 63.3% from the year before. Over ten years it grew 11.2% a year on average. The highest annual figure on record is $894.30M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$791.30M+63.3%
FY2024Dec 31, 2024$484.60M-43.2%
FY2023Dec 31, 2023$853.90M-4.5%
FY2022Dec 31, 2022$894.30M+17.3%
FY2021Dec 31, 2021$762.60M+23.9%
FY2020Dec 31, 2020$615.50M+40.2%
FY2019Dec 31, 2019$439.10M+30.1%
FY2018Dec 31, 2018$337.40M+43.0%
FY2017Dec 31, 2017$235.90M+16.2%
FY2016Dec 31, 2016$203.00M-26.1%
FY2015Dec 31, 2015$274.60M+7.6%
FY2014Dec 31, 2014$255.30M+7.5%
FY2013Dec 31, 2013$237.50M+36.3%
FY2012Dec 31, 2012$174.30M+47.3%
FY2011Dec 31, 2011$118.30M+6.8%
FY2010Dec 31, 2010$110.80M+33.3%
FY2009Dec 31, 2009$83.10M-4.7%
FY2008Dec 31, 2008$87.20M-19.6%
FY2007Dec 31, 2007$108.40M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$464.10M-26.2%
Q2 FY2026Jun 30, 2026$435.80M-14.5%
Q1 FY2026Mar 31, 2026$521.40M+29.0%
Q4 FY2025Dec 31, 2025$791.30M+63.3%
Q3 FY2025Sep 30, 2025$628.50M+28.0%
Q2 FY2025Jun 30, 2025$509.70M+14.2%
Q1 FY2025Mar 31, 2025$404.20M-32.8%
Q4 FY2024Dec 31, 2024$484.60M-43.2%
Q3 FY2024Sep 30, 2024$490.90M-45.4%
Q2 FY2024Jun 30, 2024$446.20M-44.0%
Q1 FY2024Mar 31, 2024$601.80M-32.1%
Q4 FY2023Dec 31, 2023$853.90M-4.5%
Q3 FY2023Sep 30, 2023$898.60M+23.3%
Q2 FY2023Jun 30, 2023$796.30M+10.8%
Q1 FY2023Mar 31, 2023$886.30M+32.7%
Q4 FY2022Dec 31, 2022$894.30M+17.3%
Q3 FY2022Sep 30, 2022$729.00M+6.0%
Q2 FY2022Jun 30, 2022$718.50M+24.7%
Q1 FY2022Mar 31, 2022$667.70M+38.0%
Q4 FY2021Dec 31, 2021$762.60M+23.9%
Q3 FY2021Sep 30, 2021$688.00M+32.5%
Q2 FY2021Jun 30, 2021$576.20M+29.2%
Q1 FY2021Mar 31, 2021$483.70M+44.3%
Q4 FY2020Dec 31, 2020$615.50M+40.2%
Q3 FY2020Sep 30, 2020$519.40M+31.2%
Q2 FY2020Jun 30, 2020$445.90M+36.5%
Q1 FY2020Mar 31, 2020$335.30M+26.3%
Q4 FY2019Dec 31, 2019$439.10M+30.1%
Q3 FY2019Sep 30, 2019$396.00M+33.2%
Q2 FY2019Jun 30, 2019$326.70M+44.9%
Q1 FY2019Mar 31, 2019$265.50M+32.9%
Q4 FY2018Dec 31, 2018$337.40M+43.0%
Q3 FY2018Sep 30, 2018$297.30M+10.4%
Q2 FY2018Jun 30, 2018$225.50M-0.5%
Q1 FY2018Mar 31, 2018$199.80M+17.9%
Q4 FY2017Dec 31, 2017$235.90M+16.2%
Q3 FY2017Sep 30, 2017$269.30M–
Q2 FY2017Jun 30, 2017$226.60M–
Q1 FY2017Mar 31, 2017$169.40M–
Q4 FY2016Dec 31, 2016$203.00M–

More West Pharmaceutical Services figures

See a number that looks wrong?